"Lipopeptides" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds consisting of a short peptide chain conjugated with an acyl chain.
| Descriptor ID |
D055666
|
| MeSH Number(s) |
D10.477 D12.644.365
|
| Concept/Terms |
Anionic Lipopeptides- Anionic Lipopeptides
- Lipopeptides, Anionic
- Anionic Lipopeptide
- Lipopeptide, Anionic
Cationic Lipopeptides- Cationic Lipopeptides
- Lipopeptides, Cationic
- Cationic Lipopeptide
- Lipopeptide, Cationic
|
Below are MeSH descriptors whose meaning is more general than "Lipopeptides".
Below are MeSH descriptors whose meaning is more specific than "Lipopeptides".
This graph shows the total number of publications written about "Lipopeptides" by people in this website by year, and whether "Lipopeptides" was a major or minor topic of these publications.
View timeline visualization
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 0 | 1 | 1 |
| 2001 | 0 | 2 | 2 |
| 2004 | 0 | 3 | 3 |
| 2005 | 0 | 5 | 5 |
| 2006 | 0 | 5 | 5 |
| 2007 | 0 | 5 | 5 |
| 2008 | 2 | 8 | 10 |
| 2009 | 6 | 4 | 10 |
| 2010 | 7 | 2 | 9 |
| 2011 | 3 | 7 | 10 |
| 2012 | 4 | 1 | 5 |
| 2013 | 5 | 3 | 8 |
| 2014 | 5 | 3 | 8 |
| 2015 | 2 | 3 | 5 |
| 2016 | 6 | 4 | 10 |
| 2017 | 2 | 7 | 9 |
| 2018 | 0 | 1 | 1 |
| 2019 | 9 | 1 | 10 |
| 2020 | 2 | 1 | 3 |
| 2021 | 1 | 0 | 1 |
| 2022 | 0 | 1 | 1 |
| 2023 | 1 | 1 | 2 |
| 2024 | 3 | 1 | 4 |
Below are the most recent publications written about "Lipopeptides" by people in Profiles.
-
Rezafungin versus caspofungin for patients with candidaemia or invasive candidiasis in the intensive care unit: pooled analyses of the ReSTORE and STRIVE randomised trials. Crit Care. 2024 Oct 28; 28(1):348.
-
TLR Engagement Induces an Alternate Pathway for BCR Signaling that Results in PKCδ Phosphorylation. J Immunol. 2024 Jun 01; 212(11):1639-1646.
-
Outcomes by Candida spp. in the ReSTORE Phase 3 trial of rezafungin versus caspofungin for candidemia and/or invasive candidiasis. Antimicrob Agents Chemother. 2024 May 02; 68(5):e0158423.
-
Optical Control of Proteasomal Protein Degradation with a Photoswitchable Lipopeptide. Angew Chem Int Ed Engl. 2024 02 19; 63(8):e202314791.
-
Efficacy and safety of rezafungin and caspofungin in candidaemia and invasive candidiasis: pooled data from two prospective randomised controlled trials. Lancet Infect Dis. 2024 Mar; 24(3):319-328.
-
Resistance mechanisms for Gram-negative bacteria-specific lipopeptides, turnercyclamycins, differ from that of colistin. Microbiol Spectr. 2023 Dec 12; 11(6):e0230623.
-
Antillatoxin-Stimulated Neurite Outgrowth Involves the Brain-Derived Neurotrophic Factor (BDNF) - Tropomyosin Related Kinase B (TrkB) Signaling Pathway. J Nat Prod. 2022 03 25; 85(3):562-571.
-
Therapeutic Drug Monitoring of the Echinocandin Antifungal Agents: Is There a Role in Clinical Practice? A Position Statement of the Anti-Infective Drugs Committee of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology. Ther Drug Monit. 2022 02 01; 44(1):198-214.
-
Luquilloamides, Cytotoxic Lipopeptides from a Puerto Rican Collection of the Filamentous Marine Cyanobacterium Oscillatoria sp. J Org Chem. 2022 01 21; 87(2):1043-1055.
-
TLR2 and Dectin-1 Signaling in Mouse Hematopoietic Stem and Progenitor Cells Impacts the Ability of the Antigen Presenting Cells They Produce to Activate CD4 T Cells. Cells. 2020 05 25; 9(5).